David Hoang
Stock Analyst at Deutsche Bank
(4.72)
# 675
Out of 4,429 analysts
112
Total ratings
65.4%
Success rate
28.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Hoang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics | Downgraded: Hold | $118 → $135 | $132.55 | +1.85% | 4 | Jun 22, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $420 → $374 | $303.39 | +23.27% | 9 | Jun 2, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 → $31 | $24.05 | +28.90% | 9 | May 22, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $88 → $102 | $100.32 | +1.67% | 3 | May 12, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Hold | $140 → $155 | $161.62 | -4.10% | 10 | May 7, 2026 | |
| AXSM Axsome Therapeutics | Rated: Buy | $281 → $280 | $247.85 | +12.97% | 9 | May 5, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Sell | $12 → $14 | $17.65 | -20.68% | 23 | Mar 26, 2026 | |
| ATAI AtaiBeckley | Initiated Coverage: Buy | $12 | $4.05 | +196.30% | 1 | Mar 26, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $60 → $90 | $54.79 | +64.26% | 9 | Mar 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $255 → $226 | $225.92 | +0.04% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36 → $30 | $33.43 | -10.26% | 6 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $45 | $46.02 | -2.22% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $29 | $22.09 | +31.28% | 9 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $15.50 | n/a | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $2.40 | n/a | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $8.30 | n/a | 3 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $3.72 | n/a | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $220 | $286.41 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $82.00 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 → $3 | $0.1642 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $0.84 | n/a | 1 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $73 | $343.43 | n/a | 1 | Mar 12, 2020 |
Apogee Therapeutics
Jun 22, 2026
Downgraded: Hold
Price Target: $118 → $135
Current: $132.55
Upside: +1.85%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $420 → $374
Current: $303.39
Upside: +23.27%
Denali Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $35 → $31
Current: $24.05
Upside: +28.90%
Spyre Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $88 → $102
Current: $100.32
Upside: +1.67%
Neurocrine Biosciences
May 7, 2026
Maintained: Hold
Price Target: $140 → $155
Current: $161.62
Upside: -4.10%
Axsome Therapeutics
May 5, 2026
Rated: Buy
Price Target: $281 → $280
Current: $247.85
Upside: +12.97%
Sarepta Therapeutics
Mar 26, 2026
Maintained: Sell
Price Target: $12 → $14
Current: $17.65
Upside: -20.68%
AtaiBeckley
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.05
Upside: +196.30%
Xenon Pharmaceuticals
Mar 10, 2026
Maintained: Buy
Price Target: $60 → $90
Current: $54.79
Upside: +64.26%
Jazz Pharmaceuticals
Mar 5, 2026
Maintained: Buy
Price Target: $255 → $226
Current: $225.92
Upside: +0.04%
Feb 25, 2026
Maintained: Hold
Price Target: $36 → $30
Current: $33.43
Upside: -10.26%
Nov 13, 2025
Maintained: Buy
Price Target: $52 → $45
Current: $46.02
Upside: -2.22%
Sep 25, 2025
Maintained: Buy
Price Target: $35 → $29
Current: $22.09
Upside: +31.28%
Feb 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $15.50
Upside: n/a
Jul 25, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $2.40
Upside: n/a
Jul 17, 2024
Maintained: Buy
Price Target: $16
Current: $8.30
Upside: n/a
Mar 6, 2024
Maintained: Buy
Price Target: $16
Current: $3.72
Upside: n/a
Apr 26, 2023
Initiated Coverage: Hold
Price Target: $220
Current: $286.41
Upside: n/a
Apr 26, 2023
Initiated Coverage: Buy
Price Target: $80
Current: $82.00
Upside: n/a
Dec 7, 2022
Downgraded: Hold
Price Target: $24 → $3
Current: $0.1642
Upside: n/a
Sep 30, 2020
Maintained: Buy
Price Target: $19
Current: $0.84
Upside: n/a
Mar 12, 2020
Initiated Coverage: Buy
Price Target: $73
Current: $343.43
Upside: n/a